Saranacentral Bajatama Tbk PT
IDX:BAJA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Saranacentral Bajatama Tbk PT
IDX:BAJA
|
ID |
|
Micreed Co Ltd
TSE:7687
|
JP |
|
A
|
AstraZeneca PLC
LSE:0A4J
|
UK |
|
K
|
Kukbo Co Ltd
KRX:001140
|
KR |
|
S
|
Sa Sa International Holdings Ltd
OTC:SSILF
|
HK |
|
A
|
American Integrity Insurance Group Inc
NYSE:AII
|
US |
|
A
|
Alfavision Overseas (India) Ltd
BSE:531156
|
IN |
|
Daikaffil Chemicals India Ltd
BSE:530825
|
IN |
|
I
|
Intelligent Digital Integrated Security Co Ltd
KOSDAQ:143160
|
KR |
|
Harvard Apparatus Regenerative Technology Inc
OTC:HRGN
|
US |
|
H
|
Hydrogene De France SA
F:9QW
|
FR |
|
K
|
Kao Corp
XBER:KAO
|
JP |
|
T
|
Trivium Real Estate Socimi SA
MAD:YTRI
|
ES |
|
Q
|
Quantum Healthcare Ltd
SGX:V8Y
|
SG |
Balance Sheet
Balance Sheet Decomposition
Saranacentral Bajatama Tbk PT
Saranacentral Bajatama Tbk PT
Balance Sheet
Saranacentral Bajatama Tbk PT
| Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
1 947
|
11 163
|
1 294
|
113 555
|
66 720
|
4 821
|
22 905
|
3 481
|
3 867
|
12 100
|
10 311
|
17 242
|
85 991
|
67 915
|
23 471
|
7 828
|
45 402
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
4 821
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
67 915
|
0
|
7 828
|
45 402
|
|
| Cash Equivalents |
1 947
|
11 163
|
1 294
|
113 555
|
66 720
|
0
|
22 905
|
3 481
|
3 867
|
12 100
|
10 311
|
17 242
|
85 991
|
0
|
23 471
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
61 415
|
0
|
30 130
|
48 085
|
|
| Total Receivables |
67 993
|
114 056
|
105 952
|
141 595
|
179 351
|
148 686
|
211 977
|
284 098
|
242 634
|
172 780
|
192 516
|
170 184
|
123 097
|
64 699
|
139 657
|
155 610
|
146 315
|
|
| Accounts Receivables |
67 937
|
93 911
|
105 917
|
141 580
|
179 339
|
148 685
|
211 977
|
284 094
|
242 376
|
172 761
|
192 496
|
169 006
|
123 097
|
64 686
|
139 378
|
155 609
|
146 294
|
|
| Other Receivables |
56
|
20 145
|
35
|
15
|
12
|
1
|
0
|
5
|
259
|
18
|
20
|
1 179
|
0
|
13
|
279
|
1
|
20
|
|
| Inventory |
128 046
|
121 042
|
172 183
|
175 636
|
283 335
|
330 888
|
346 962
|
322 718
|
452 204
|
481 055
|
402 222
|
378 783
|
299 112
|
325 439
|
337 650
|
316 251
|
293 981
|
|
| Other Current Assets |
15 096
|
11 707
|
26 796
|
43 891
|
53 487
|
61 544
|
71 122
|
56 963
|
51 125
|
61 305
|
87 119
|
70 237
|
54 388
|
24 255
|
37 006
|
10 120
|
2 076
|
|
| Total Current Assets |
213 082
|
257 968
|
306 225
|
474 677
|
582 894
|
545 940
|
652 967
|
667 261
|
749 830
|
727 240
|
692 169
|
636 446
|
562 588
|
543 722
|
537 784
|
519 940
|
535 858
|
|
| PP&E Net |
228 483
|
232 565
|
214 251
|
197 228
|
235 095
|
268 722
|
277 032
|
249 498
|
220 564
|
200 832
|
196 211
|
191 225
|
182 080
|
174 541
|
157 027
|
139 728
|
115 192
|
|
| PP&E Gross |
228 483
|
232 565
|
214 251
|
197 228
|
235 095
|
268 722
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
174 541
|
0
|
139 728
|
115 192
|
|
| Accumulated Depreciation |
103 235
|
118 697
|
141 637
|
165 008
|
189 545
|
216 930
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
457 333
|
0
|
523 493
|
553 804
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
29 994
|
17 354
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
322
|
0
|
|
| Other Long-Term Assets |
377
|
1 030
|
4 413
|
1 708
|
2 463
|
28 267
|
29 447
|
31 924
|
12 233
|
18 377
|
12 802
|
9 200
|
15 758
|
7 910
|
36 530
|
36 451
|
36 183
|
|
| Total Assets |
441 942
N/A
|
491 563
+11%
|
524 889
+7%
|
673 613
+28%
|
820 451
+22%
|
842 928
+3%
|
959 445
+14%
|
948 683
-1%
|
982 627
+4%
|
946 449
-4%
|
901 182
-5%
|
836 871
-7%
|
760 425
-9%
|
726 173
-5%
|
731 341
+1%
|
726 111
-1%
|
704 587
-3%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
63 089
|
83 297
|
56 381
|
90 029
|
110 576
|
251 323
|
181 631
|
165 425
|
170 720
|
162 048
|
147 890
|
137 840
|
122 732
|
57 424
|
80 012
|
116 060
|
82 931
|
|
| Accrued Liabilities |
6 564
|
12 895
|
18 552
|
3 912
|
17 161
|
21 309
|
27 976
|
40 578
|
47 990
|
53 972
|
66 099
|
71 084
|
78 045
|
103 484
|
101 486
|
112 668
|
129 586
|
|
| Short-Term Debt |
180 861
|
185 370
|
288 324
|
131 094
|
210 627
|
116 012
|
307 266
|
279 444
|
267 214
|
257 071
|
295 871
|
240 799
|
122 164
|
34 631
|
104 392
|
57 324
|
94 624
|
|
| Current Portion of Long-Term Debt |
0
|
5 058
|
5 128
|
7 505
|
6 199
|
6 830
|
0
|
0
|
0
|
0
|
0
|
0
|
64
|
70
|
77
|
85
|
38
|
|
| Other Current Liabilities |
67 825
|
60 867
|
12 902
|
194 510
|
210 042
|
268 961
|
263 786
|
292 539
|
289 891
|
287 066
|
301 505
|
298 611
|
296 711
|
16 329
|
4 119
|
3 387
|
2 090
|
|
| Total Current Liabilities |
318 339
|
347 487
|
381 287
|
427 050
|
554 605
|
664 434
|
780 658
|
777 987
|
775 815
|
760 157
|
811 365
|
748 333
|
619 717
|
211 939
|
290 086
|
289 523
|
309 269
|
|
| Long-Term Debt |
32 850
|
22 328
|
16 228
|
8 862
|
5 404
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
270
|
287 557
|
318 370
|
313 477
|
330 117
|
|
| Other Liabilities |
1 016
|
1 442
|
1 925
|
2 669
|
3 404
|
4 248
|
7 821
|
9 068
|
10 309
|
14 276
|
13 295
|
14 351
|
12 599
|
12 593
|
12 696
|
12 100
|
8 037
|
|
| Total Liabilities |
352 205
N/A
|
371 257
+5%
|
399 440
+8%
|
438 580
+10%
|
563 413
+28%
|
668 682
+19%
|
788 479
+18%
|
787 055
0%
|
786 124
0%
|
774 433
-1%
|
824 660
+6%
|
762 684
-8%
|
632 586
-17%
|
512 089
-19%
|
621 152
+21%
|
615 100
-1%
|
647 423
+5%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
77 672
|
77 672
|
77 672
|
180 000
|
180 000
|
180 000
|
180 000
|
180 000
|
180 000
|
180 000
|
180 000
|
180 000
|
180 000
|
180 000
|
180 000
|
180 000
|
180 000
|
|
| Retained Earnings |
12 065
|
42 634
|
47 777
|
2 635
|
19 380
|
63 413
|
64 919
|
74 269
|
39 875
|
65 643
|
161 138
|
163 472
|
109 820
|
23 575
|
127 469
|
126 648
|
180 495
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
57 667
|
57 659
|
57 659
|
57 659
|
57 659
|
57 659
|
57 659
|
57 659
|
57 659
|
57 659
|
57 659
|
57 659
|
57 659
|
57 659
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 763
|
1 281
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
89 737
N/A
|
120 306
+34%
|
125 449
+4%
|
235 033
+87%
|
257 039
+9%
|
174 246
-32%
|
170 966
-2%
|
161 628
-5%
|
196 503
+22%
|
172 016
-12%
|
76 521
-56%
|
74 187
-3%
|
127 839
+72%
|
214 084
+67%
|
110 189
-49%
|
111 011
+1%
|
57 164
-49%
|
|
| Total Liabilities & Equity |
441 942
N/A
|
491 563
+11%
|
524 889
+7%
|
673 613
+28%
|
820 451
+22%
|
842 928
+3%
|
959 445
+14%
|
948 683
-1%
|
982 627
+4%
|
946 449
-4%
|
901 182
-5%
|
836 871
-7%
|
760 425
-9%
|
726 173
-5%
|
731 341
+1%
|
726 111
-1%
|
704 587
-3%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
1 400
|
1 400
|
1 400
|
1 800
|
1 800
|
1 800
|
1 800
|
1 800
|
1 800
|
1 800
|
1 800
|
1 800
|
1 800
|
1 800
|
1 800
|
1 800
|
1 800
|
|